iodine has been researched along with Pancreatic Neoplasms in 21 studies
Iodine: A nonmetallic element of the halogen group that is represented by the atomic symbol I, atomic number 53, and atomic weight of 126.90. It is a nutritionally essential element, especially important in thyroid hormone synthesis. In solution, it has anti-infective properties and is used topically.
diiodine : Molecule comprising two covalently bonded iodine atoms with overall zero charge..
Pancreatic Neoplasms: Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA).
| Excerpt | Relevance | Reference |
|---|---|---|
| "To determine the iodine load per body weight (ILPBW) that is minimally required for the detection of pancreatic adenocarcinoma for 80kVp CT imaging." | 9.22 | Determination of the least amount of iodine load required for the detection of pancreatic adenocarcinoma at 80-kVp CT. ( Goshima, S; Kanematsu, M; Kawada, H; Kawai, N; Koyasu, H; Matsuo, M; Miyoshi, T; Noda, Y; T Bae, K; Watanabe, H, 2016) |
| "To determine the iodine load per body weight (ILPBW) that is minimally required for the detection of pancreatic adenocarcinoma for 80kVp CT imaging." | 5.22 | Determination of the least amount of iodine load required for the detection of pancreatic adenocarcinoma at 80-kVp CT. ( Goshima, S; Kanematsu, M; Kawada, H; Kawai, N; Koyasu, H; Matsuo, M; Miyoshi, T; Noda, Y; T Bae, K; Watanabe, H, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (23.81) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (14.29) | 29.6817 |
| 2010's | 9 (42.86) | 24.3611 |
| 2020's | 4 (19.05) | 2.80 |
| Authors | Studies |
|---|---|
| Noid, G | 1 |
| Godfrey, G | 1 |
| Hall, W | 1 |
| Shah, J | 1 |
| Paulson, E | 1 |
| Knechtges, P | 1 |
| Erickson, B | 1 |
| Allen Li, X | 1 |
| Koch, V | 1 |
| Weitzer, N | 1 |
| Dos Santos, DP | 1 |
| Gruenewald, LD | 1 |
| Mahmoudi, S | 1 |
| Martin, SS | 1 |
| Eichler, K | 1 |
| Bernatz, S | 1 |
| Gruber-Rouh, T | 1 |
| Booz, C | 1 |
| Hammerstingl, RM | 1 |
| Biciusca, T | 1 |
| Rosbach, N | 1 |
| Gökduman, A | 1 |
| D'Angelo, T | 1 |
| Finkelmeier, F | 1 |
| Yel, I | 1 |
| Alizadeh, LS | 1 |
| Sommer, CM | 1 |
| Cengiz, D | 1 |
| Vogl, TJ | 1 |
| Albrecht, MH | 1 |
| Ohira, S | 1 |
| Ikawa, T | 1 |
| Kanayama, N | 1 |
| Minamitani, M | 1 |
| Kihara, S | 1 |
| Inui, S | 1 |
| Ueda, Y | 1 |
| Miyazaki, M | 1 |
| Yamashita, H | 1 |
| Nishio, T | 1 |
| Koizumi, M | 1 |
| Nakagawa, K | 1 |
| Konishi, K | 1 |
| El Kayal, N | 1 |
| Lennartz, S | 1 |
| Ekdawi, S | 1 |
| Holz, J | 1 |
| Slebocki, K | 1 |
| Haneder, S | 1 |
| Wybranski, C | 1 |
| Mohallel, A | 1 |
| Eid, M | 1 |
| Grüll, H | 1 |
| Persigehl, T | 1 |
| Borggrefe, J | 1 |
| Maintz, D | 1 |
| Heneweer, C | 1 |
| Li, WX | 1 |
| Miao, F | 2 |
| Xu, XQ | 1 |
| Zhang, J | 1 |
| Wu, ZY | 1 |
| Chen, KM | 1 |
| Yan, FH | 1 |
| Lin, XZ | 1 |
| Skornitzke, S | 3 |
| Fritz, F | 2 |
| Mayer, P | 1 |
| Koell, M | 1 |
| Hansen, J | 2 |
| Pahn, G | 2 |
| Hackert, T | 1 |
| Kauczor, HU | 3 |
| Stiller, W | 3 |
| Aslan, S | 1 |
| Camlidag, I | 1 |
| Nural, MS | 1 |
| Noda, Y | 2 |
| Goshima, S | 2 |
| Miyoshi, T | 2 |
| Kawada, H | 2 |
| Kawai, N | 2 |
| Tanahashi, Y | 1 |
| Matsuo, M | 2 |
| Klauss, M | 1 |
| Grenacher, L | 1 |
| Yin, Q | 1 |
| Zou, X | 1 |
| Zai, X | 1 |
| Wu, Z | 1 |
| Wu, Q | 1 |
| Jiang, X | 1 |
| Chen, H | 1 |
| Watanabe, H | 1 |
| Koyasu, H | 1 |
| Kanematsu, M | 1 |
| T Bae, K | 1 |
| Belousova, E | 1 |
| Karmazanovsky, G | 1 |
| Kriger, A | 1 |
| Kalinin, D | 1 |
| Mannelli, L | 1 |
| Glotov, A | 1 |
| Karelskaya, N | 1 |
| Paklina, O | 1 |
| Kaldarov, A | 1 |
| Groot-Wassink, T | 1 |
| Aboagye, EO | 1 |
| Glaser, M | 1 |
| Lemoine, NR | 1 |
| Vassaux, G | 1 |
| HARPER, PV | 2 |
| LATHROP, KA | 1 |
| LATHROP, K | 1 |
| AFIFI, F | 1 |
| HARTMANN, L | 1 |
| LOVERDO, A | 1 |
| FAUVERT, R | 1 |
| BASTOS, J | 1 |
| DE AZEVEDO, C | 1 |
| COSTA, AC | 1 |
| BONIFACIO, B | 1 |
| Döbert, N | 1 |
| Hamscho, N | 1 |
| Bergert, ER | 1 |
| Oeschger, S | 1 |
| Berner, U | 1 |
| Goellner, J | 1 |
| Menzel, C | 1 |
| Morris, JC | 1 |
| Grünwald, F | 1 |
| Fenchel, S | 1 |
| Fleiter, TR | 1 |
| Aschoff, AJ | 1 |
| van Gessel, R | 1 |
| Brambs, HJ | 1 |
| Merkle, EM | 1 |
| Weinstein, GS | 1 |
| O'Dorisio, TM | 1 |
| Joehl, RJ | 1 |
| Pokorney, B | 1 |
| Koch, KL | 1 |
2 trials available for iodine and Pancreatic Neoplasms
| Article | Year |
|---|---|
Determination of the least amount of iodine load required for the detection of pancreatic adenocarcinoma at 80-kVp CT.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Contrast Media; Female; Humans; Iodine; Iopamidol; Male; Mi | 2016 |
Effect of iodine concentration of contrast media on contrast enhancement in multislice CT of the pancreas.
Topics: Adult; Aged; Cohort Studies; Contrast Media; Female; Humans; Iodine; Iodine Radioisotopes; Iopamidol | 2004 |
19 other studies available for iodine and Pancreatic Neoplasms
| Article | Year |
|---|---|
Predicting Treatment Response From Extracellular Volume Fraction for Chemoradiation Therapy of Pancreatic Cancer.
Topics: CA-19-9 Antigen; Contrast Media; Humans; Iodine; Pancreatic Neoplasms; Tomography, X-Ray Computed | 2023 |
Predicting Treatment Response From Extracellular Volume Fraction for Chemoradiation Therapy of Pancreatic Cancer.
Topics: CA-19-9 Antigen; Contrast Media; Humans; Iodine; Pancreatic Neoplasms; Tomography, X-Ray Computed | 2023 |
Predicting Treatment Response From Extracellular Volume Fraction for Chemoradiation Therapy of Pancreatic Cancer.
Topics: CA-19-9 Antigen; Contrast Media; Humans; Iodine; Pancreatic Neoplasms; Tomography, X-Ray Computed | 2023 |
Predicting Treatment Response From Extracellular Volume Fraction for Chemoradiation Therapy of Pancreatic Cancer.
Topics: CA-19-9 Antigen; Contrast Media; Humans; Iodine; Pancreatic Neoplasms; Tomography, X-Ray Computed | 2023 |
Multiparametric detection and outcome prediction of pancreatic cancer involving dual-energy CT, diffusion-weighted MRI, and radiomics.
Topics: Female; Humans; Iodine; Magnetic Resonance Imaging; Pancreatic Neoplasms; Prognosis; Retrospective S | 2023 |
Dual-energy computed tomography-based iodine concentration as a predictor of histopathological response to preoperative chemoradiotherapy for pancreatic cancer.
Topics: Chemoradiotherapy; Contrast Media; Humans; Iodine; Pancreatic Neoplasms; Retrospective Studies; Tomo | 2023 |
Dual-energy computed tomography-based iodine concentration as a predictor of histopathological response to preoperative chemoradiotherapy for pancreatic cancer.
Topics: Chemoradiotherapy; Contrast Media; Humans; Iodine; Pancreatic Neoplasms; Retrospective Studies; Tomo | 2023 |
Dual-energy computed tomography-based iodine concentration as a predictor of histopathological response to preoperative chemoradiotherapy for pancreatic cancer.
Topics: Chemoradiotherapy; Contrast Media; Humans; Iodine; Pancreatic Neoplasms; Retrospective Studies; Tomo | 2023 |
Dual-energy computed tomography-based iodine concentration as a predictor of histopathological response to preoperative chemoradiotherapy for pancreatic cancer.
Topics: Chemoradiotherapy; Contrast Media; Humans; Iodine; Pancreatic Neoplasms; Retrospective Studies; Tomo | 2023 |
Value of spectral detector computed tomography for assessment of pancreatic lesions.
Topics: Adult; Aged; Contrast Media; Humans; Iodine; Middle Aged; Observer Variation; Pancreatic Neoplasms; | 2019 |
Pancreatic Neuroendocrine Neoplasms: CT Spectral Imaging in Grading.
Topics: Diagnosis, Differential; Humans; Iodine; Pancreatic Neoplasms; Retrospective Studies; ROC Curve; Tom | 2021 |
Dual-energy CT iodine maps as an alternative quantitative imaging biomarker to abdominal CT perfusion: determination of appropriate trigger delays for acquisition using bolus tracking.
Topics: Biomarkers; Contrast Media; Humans; Iodine; Pancreas; Pancreatic Neoplasms; Prospective Studies; Rad | 2018 |
Lower energy levels and iodine-based material decomposition images increase pancreatic ductal adenocarcinoma conspicuity on rapid kV-switching dual-energy CT.
Topics: Adenocarcinoma; Aged; Aged, 80 and over; Carcinoma, Pancreatic Ductal; Contrast Media; Female; Human | 2019 |
Assessing Chemotherapeutic Response in Pancreatic Ductal Adenocarcinoma: Histogram Analysis of Iodine Concentration and CT Number in Single-Source Dual-Energy CT.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Pancreatic Ductal; Feasibility Studies; F | 2018 |
Measuring Dynamic CT Perfusion Based on Time-Resolved Quantitative DECT Iodine Maps: Comparison to Conventional Perfusion at 80 kVp for Pancreatic Carcinoma.
Topics: Absorptiometry, Photon; Contrast Media; Humans; Iodine; Pancreas; Pancreatic Neoplasms; Radiographic | 2019 |
Measuring Dynamic CT Perfusion Based on Time-Resolved Quantitative DECT Iodine Maps: Comparison to Conventional Perfusion at 80 kVp for Pancreatic Carcinoma.
Topics: Absorptiometry, Photon; Contrast Media; Humans; Iodine; Pancreas; Pancreatic Neoplasms; Radiographic | 2019 |
Measuring Dynamic CT Perfusion Based on Time-Resolved Quantitative DECT Iodine Maps: Comparison to Conventional Perfusion at 80 kVp for Pancreatic Carcinoma.
Topics: Absorptiometry, Photon; Contrast Media; Humans; Iodine; Pancreas; Pancreatic Neoplasms; Radiographic | 2019 |
Measuring Dynamic CT Perfusion Based on Time-Resolved Quantitative DECT Iodine Maps: Comparison to Conventional Perfusion at 80 kVp for Pancreatic Carcinoma.
Topics: Absorptiometry, Photon; Contrast Media; Humans; Iodine; Pancreas; Pancreatic Neoplasms; Radiographic | 2019 |
Correlation of quantitative dual-energy computed tomography iodine maps and abdominal computed tomography perfusion measurements: are single-acquisition dual-energy computed tomography iodine maps more than a reduced-dose surrogate of conventional compute
Topics: Contrast Media; Humans; Iodine; Pancreas; Pancreatic Neoplasms; Radiation Dosage; Radiographic Image | 2015 |
Pancreatic ductal adenocarcinoma and chronic mass-forming pancreatitis: Differentiation with dual-energy MDCT in spectral imaging mode.
Topics: Adenocarcinoma; Aged; Carcinoma, Pancreatic Ductal; Contrast Media; Diagnosis, Differential; Female; | 2015 |
Contrast-enhanced MDCT in patients with pancreatic neuroendocrine tumours: correlation with histological findings and diagnostic performance in differentiation between tumour grades.
Topics: Contrast Media; Diagnosis, Differential; Female; Humans; Iodine; Male; Middle Aged; Multidetector Co | 2017 |
Adenovirus biodistribution and noninvasive imaging of gene expression in vivo by positron emission tomography using human sodium/iodide symporter as reporter gene.
Topics: Adenocarcinoma; Adenoviruses, Human; Animals; DNA, Complementary; DNA, Recombinant; Gene Expression; | 2002 |
Isotope therapy for carcinoma of the pancrease.
Topics: Carcinoma; Humans; Iodine; Iodine Radioisotopes; Isotopes; Pancreatic Neoplasms; Pancrelipase; Radio | 1955 |
Implant radiation therapy for carcinoma of the pancreas.
Topics: Brachytherapy; Carcinoma; Humans; Iodine; Iodine Radioisotopes; Pancreas; Pancreatic Neoplasms | 1958 |
[EXPLORATION OF DIGESTIVE FUNCTION BY MEANS OF CASEIN LABELLED WITH RADIOACTIVE IODINE I-131].
Topics: Caseins; Dialysis; Digestion; Feces; Gastrectomy; Gastroenterology; Humans; Hydrochloric Acid; Iodin | 1963 |
[STUDY OF THE PORTAL CIRCULATION WITH RADIOACTIVE IODINE].
Topics: Anemia; Anemia, Hemolytic; Blood Circulation Time; Humans; Hypertension; Hypertension, Portal; Iodin | 1963 |
Pancreatic carcinoma with positive iodine uptake lacking NIS-protein-expression.
Topics: Carcinoma; Diagnosis, Differential; Female; Humans; Immunohistochemistry; Iodine; Middle Aged; Neopl | 2003 |
Exacerbation of diarrhea after iodinated contrast agents in a patient with VIPoma.
Topics: Adenoma, Islet Cell; Contrast Media; Diarrhea; Diatrizoate; Humans; Iodine; Iopanoic Acid; Liver Neo | 1985 |